IPIX OTC
Innovation Pharmaceuticals Inc.
1W: +0.0%
1M: +19900.0%
3M: -33.3%
YTD: -80.0%
1Y: -93.3%
3Y: -98.0%
5Y: -99.9%
$0.00
-0.00 (-80.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$2M
+66.5% ▲
Capital Expenditures
$60K
+25.0% ▲
5Y CAGR: -12.5%
Free Cash Flow
-$2M
+65.9% ▲
Dividends Paid
$86K
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2M
+64.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$9M | -$7M | -$14M | -$7M | -$3M |
| Depreciation & Amort. | $371K | $373K | $378K | $382K | $373K |
| Stock-Based Comp. | $1M | $427K | $183K | $583K | $207K |
| Change in Working Capital | -$1M | -$113K | -$847K | -$372K | $310K |
| Other Non-Cash Items | $2M | -$50K | $5M | $168K | $172K |
| Operating Cash Flow | -$6M | -$4M | -$9M | -$6M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | -$86K | -$91K | -$72K | -$80K | -$60K |
| Acquisitions (Net) | $40K | $0 | $0 | -$4M | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$46 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$46K | -$91K | -$72K | -$4M | -$60K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $5M | -$1M | -$37K |
| Stock Repurchased | -$91K | -$55K | -$670K | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | -$86K |
| Other Financing | $3M | $10M | -$66K | $0 | $0 |
| Financing Cash Flow | $5M | $10M | $14M | $4M | -$123K |
| Net Change in Cash | -$2M | $5M | $4M | -$6M | -$2M |
| Cash End of Period | $579K | $6M | $10M | $4M | $2M |
| Free Cash Flow | -$6M | -$4M | -$10M | -$6M | -$2M |